首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1391937

同种异体干细胞移植市场：按原料、按应用、按最终用户、按细胞类型、按地区

Allogeneic Stem Cell Transplantation Market, By Source, By Application, By End User, By Cell Type, By Geography

出版日期: 2023年11月20日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3个工作天内

价格

简介目录

异体干细胞移植市场规模预计将从 2023 年的 39 亿美元增加到 2030 年的 66.2 亿美元，预测期内复合年增长率为 7.8%。

报告范围		报告详情
基准年	2022年	2023年市场规模	39亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期复合年增长率	7.80%	2030年市场规模预测	66.2亿美元

图 1. 2023 年同种异体干细胞移植的全球市场占有率（按地区划分）

同种异体干细胞移植是一种将干细胞从捐赠者移植到受体的医疗程序。这些干细胞可以从多种来源获得，包括骨髓、週边血和脐带血。这种移植的目的是透过用健康细胞取代受损或生病的细胞来恢復受体器官和组织的功能。同种异体干细胞移植用于治疗多种疾病，包括癌症、遗传性疾病和某些免疫系统疾病。

由于同种异体干细胞移植治疗方法的疾病盛行率不断增加，全球同种异体干细胞移植市场正经历显着成长。此外，移植技术的进步和新治疗方法的市场开拓进一步促进了市场成长。该市场的特点是存在几家主要企业，例如 Celgene Corporation、Mesoblast Ltd.、Pluristem Therapeutics Inc. 和工业 Company Limited。

市场动态：

可以透过塑造市场的驱动因素、抑制因素和机会来分析同种异体干细胞移植市场的市场动态。

驱动因素：白血病、淋巴瘤、多发性骨髓瘤等需要干细胞移植的疾病发生率的增加是市场的主要驱动因素。此外，老年人口的增加、移植技术的进步以及干细胞库设施数量的增加也推动了市场的成长。
抑制因素：与干细胞移植相关的移植物抗宿主疾病等併发症的高成本和风险是市场的主要抑制因素。此外，某些地区对同种异体干细胞移植的潜在益处认知不足也阻碍了市场成长。
机会：开发创新治疗方法和探索异体干细胞移植的新应用代表着巨大的成长机会。此外，增加对研发活动的投资以及主要企业和研究机构之间的合作可能会推动市场成长。

本研究的主要特点

本报告详细分析了全球同种异体干细胞移植市场，包括以2022年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
它揭示了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
它提供了有关市场驱动因素、抑制因素因素、机会、新产品发布和核准、市场趋势和驱动因素、区域前景、主要企业采取的竞争策略等的重要考察。
全球同种异体干细胞移植市场的主要参与者包括 Celgene Corporation、Mesoblast Ltd.、Pluristem Therapeutics Inc.、工业等。我们根据公司亮点、产品系列、主要亮点、财务实绩和策略进行分析。
该报告为行销人员和负责人提供了宝贵的资讯，使经营团队能够就未来的产品发布、市场扩张和行销策略做出明智的资讯。
我们迎合产业内的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师，为决策提供见解。
相关人员可以从用于分析全球同种异体干细胞移植市场的各种策略矩阵中受益，并可以提高决策流程的简易性。

Celgene Corporation
Mesoblast Ltd.
Pluristem Therapeutics Inc.
MEDIPOST Co., Ltd.
Osiris Therapeutics, Inc.
Cynata Therapeutics Limited
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Cellular Biomedicine Group, Inc.
Biosolution Co., Ltd.
StemCell Technologies Inc.
Caladrius Biosciences, Inc.
TiGenix NV
ViaCord
Vericel Corporation
Regen Biopharma Inc.
Gamida Cell Ltd.
Histogenics Corporation
BrainStorm Cell Therapeutics Inc.
Lineage Cell Therapeutics, Inc.

第11章章节

调查方法
关于出版商

简介目录

Product Code: CMI6407

The allogeneic stem cell transplantation market size is expected to reach US$ 6.62 Bn by 2030, from US$ 3.90 Bn in 2023, at a CAGR of 7.8% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.90 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.80%	2030 Value Projection:	US$ 6.62 Bn

Figure 1. Global Allogeneic Stem Cell Transplantation Market Share (%), By Region, 2023

Allogeneic Stem Cell Transplantation Market - IMG1

Allogeneic stem cell transplantation is a medical procedure that involves the transfer of stem cells from a donor to a recipient. These stem cells can be obtained from various sources such as bone marrow, peripheral blood, or umbilical cord blood. The aim of this procedure is to replace damaged or diseased cells with healthy ones, thereby restoring the function of the recipient's organs or tissues. Allogeneic stem cell transplantation has been used for the treatment of a wide range of conditions including cancers, genetic disorders, and certain immune system disorders.

The global allogeneic stem cell transplantation market is witnessing significant growth due to the increasing prevalence of diseases that can be treated through this procedure. Moreover, advancements in transplantation techniques, as well as the development of new therapeutic approaches, are further contributing to the market growth. The market is characterized by the presence of several key players including Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., and Takeda Pharmaceutical Company Limited, among others.

Market Dynamics:

The market dynamics of the allogeneic stem cell transplantation market can be analyzed through the drivers, restraints, and opportunities that shape the market.

Drivers: The increasing incidence of diseases that require stem cell transplantation, such as leukemia, lymphoma, and multiple myeloma, is a major driver for the market. Additionally, the growing geriatric population, advancements in transplantation techniques, and the rise in stem cell banking facilities are also fueling the market growth.
Restraints: The high costs associated with stem cell transplantation procedures and the risk of complications, such as graft-versus-host disease, act as significant restraints for the market. Moreover, the lack of awareness about the potential benefits of allogeneic stem cell transplantation in certain regions hinders the market growth.
Opportunities: The development of innovative therapies and the exploration of new applications for allogeneic stem cell transplantation present significant growth opportunities. Moreover, increasing investments in research and development activities and collaborations between key players and research institutions can drive the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global allogeneic stem cell transplantation market, including market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It highlights potential revenue growth opportunities across different market segments and explains attractive investment proposition matrices for this market
The study offers key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key players in the global allogeneic stem cell transplantation market include Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., and Takeda Pharmaceutical Company Limited, and they are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies
The report provides valuable information to marketers and management authorities, enabling them to make informed decisions regarding future product launches, market expansion, and marketing tactics
It caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, providing them with insights for decision-making
Stakeholders can benefit from the various strategy matrices used in analyzing the global allogeneic stem cell transplantation market, enhancing ease in decision-making processes

Allogeneic Stem Cell Transplantation Market Segmentation:

By Source
- Bone Marrow
- Peripheral Blood
- Umbilical Cord Blood
- Adipose Tissue
- Dental Pulp
- Others
By Application
- Cancer
- Autoimmune Diseases
- Blood Disorders
- Cardiac Disorders
- Neurological Disorders
- Diabetes
- Others
By End User
- Hospitals
- Research Institutes
- Specialty Clinics
- Others
By Cell Type
- Allogeneic MSCs
- Allogeneic HSCs
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Allogeneic Stem Cell Transplantation Market:
- Celgene Corporation
- Mesoblast Ltd.
- Pluristem Therapeutics Inc.
- MEDIPOST Co., Ltd.
- Osiris Therapeutics, Inc.
- Cynata Therapeutics Limited
- Takeda Pharmaceutical Company Limited
- Astellas Pharma Inc.
- Cellular Biomedicine Group, Inc.
- Biosolution Co., Ltd.
- StemCell Technologies Inc.
- Caladrius Biosciences, Inc.
- TiGenix N.V.
- ViaCord
- Vericel Corporation
- Regen Biopharma Inc.
- Gamida Cell Ltd.
- Histogenics Corporation
- BrainStorm Cell Therapeutics Inc.
- Lineage Cell Therapeutics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Allogeneic Stem Cell Transplantation Market , By Source
- Allogeneic Stem Cell Transplantation Market , By Cell Type
- Allogeneic Stem Cell Transplantation Market , By Application
- Allogeneic Stem Cell Transplantation Market , By End User
- Allogeneic Stem Cell Transplantation Market , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising incidence of chronic diseases
- Restraints
High costs associated with cell therapies
- Opportunities
Increasing use of allogeneic MSCs
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Allogeneic Stem Cell Transplantation Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Allogeneic Stem Cell Transplantation Market, By Source, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Bone Marrow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Peripheral Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Umbilical Cord Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Adipose Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Dental Pulp
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Allogeneic Stem Cell Transplantation Market, By Cell Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Allogeneic MSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Allogeneic HSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Allogeneic Stem Cell Transplantation Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Blood Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Cardiac Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Allogeneic Stem Cell Transplantation Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

9. Allogeneic Stem Cell Transplantation Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mesoblast Ltd.
Pluristem Therapeutics Inc.
MEDIPOST Co., Ltd.
Osiris Therapeutics, Inc.
Cynata Therapeutics Limited
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Cellular Biomedicine Group, Inc.
Biosolution Co., Ltd.
StemCell Technologies Inc.
Caladrius Biosciences, Inc.
TiGenix N.V.
ViaCord
Vericel Corporation
Regen Biopharma Inc.
Gamida Cell Ltd.
Histogenics Corporation
BrainStorm Cell Therapeutics Inc.
Lineage Cell Therapeutics, Inc.
Analyst Views